Recurrent severe hypocalcemia following chemotherapy regimen changes in advanced breast cancer: two case reports
ConclusionsWe observed two cases of recurrent severe hypocalcemia in patients with advanced breast cancer and bone metastases after modifications to their therapy regimens. These cases differed from the typical hypocalcemia induced by bone-modifying agents. It is possible that antitumor drugs affect calcium and bone metabolism associated with bone metastases. While these cases are rare, it is crucial for oncologists to be aware of hypocalcemia not only at the initiation of bone-modifying agents but also throughout the entire antitumor therapy, as hypocalcemia can lead to fatal outcomes.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Breast Cancer | Breast Carcinoma | Calcium | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Ductal Carcinoma | Emergency Medicine | Endocrine Therapy | General Medicine | Hepatocellular Carcinoma | Herceptin | Japan Health | Liver | Liver Cancer | Lobular Carcinoma | Ovarian Cancer | Ovaries | Paraneoplastic Syndrome | Urology & Nephrology | Vitamin D3 | Vitamins | Xeloda | Xgeva